Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$9.11
+0.10 (+1.11%)
(As of 11:30 AM ET)

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Key Stats

Today's Range
$9.08
$9.29
50-Day Range
$8.65
$12.16
52-Week Range
$8.46
$27.05
Volume
4.01 million shs
Average Volume
16.04 million shs
Market Capitalization
$7.86 billion
P/E Ratio
N/A
Dividend Yield
10.98%
Price Target
$14.73
Consensus Rating
Reduce

Company Overview

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

Walgreens Boots Alliance Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 89th Percentile

Walgreens Boots Alliance scored higher than 89% of companies evaluated by MarketBeat, and ranked 47th out of 205 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Walgreens Boots Alliance has received a consensus rating of Reduce. The company's average rating score is 1.87, and is based on 2 buy ratings, 9 hold ratings, and 4 sell ratings.

  • Amount of Analyst Coverage

    Walgreens Boots Alliance has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Walgreens Boots Alliance's stock forecast and price target.
  • Earnings Growth

    Earnings for Walgreens Boots Alliance are expected to decrease by -38.11% in the coming year, from $2.86 to $1.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Walgreens Boots Alliance is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Walgreens Boots Alliance is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Walgreens Boots Alliance has a PEG Ratio of 1.02. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Walgreens Boots Alliance has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Walgreens Boots Alliance's valuation and earnings.
  • Percentage of Shares Shorted

    11.65% of the float of Walgreens Boots Alliance has been sold short.
  • Short Interest Ratio / Days to Cover

    Walgreens Boots Alliance has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Walgreens Boots Alliance has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Walgreens Boots Alliance is a leading dividend payer. It pays a dividend yield of 10.86%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Walgreens Boots Alliance does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 56.50% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.

  • Read more about Walgreens Boots Alliance's dividend.
  • Percentage of Shares Shorted

    11.65% of the float of Walgreens Boots Alliance has been sold short.
  • Short Interest Ratio / Days to Cover

    Walgreens Boots Alliance has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Walgreens Boots Alliance has recently increased by 15.20%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Walgreens Boots Alliance has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Retail/Wholesale companies.
  • News Coverage This Week

    MarketBeat has tracked 39 news articles for Walgreens Boots Alliance this week, compared to 23 articles on an average week.
  • Search Interest

    120 people have searched for WBA on MarketBeat in the last 30 days. This is an increase of 24% compared to the previous 30 days.
  • MarketBeat Follows

    Only 34 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is a decrease of -8% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Walgreens Boots Alliance insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.40% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    58.59% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Walgreens Boots Alliance's insider trading history.

WBA Stock News Headlines

Financial markets news icon
5 Oversold Stocks to Buy Right Now (WBA)
We've got you covered with a list of oversold stocks to buy right now. Learn more about oversold and overbought stocks on MarketBeat.
A Walgreens store in Bradenton, Fla., is shown on February 9, 2024. (AP Photo/Gene J. Puskar, File)
Walgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
Walgreens agreed to pay $106 million to settle lawsuits that alleged it submitted false payment claims with government health care programs for prescriptions that were never dispensed
Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
A sign hangs on the front door of Kingdom Trails in Burke, Vt
Weeks after floods, Vermont businesses struggling to get visitors to return
Two bouts of flooding in July has hampered businesses and destinations in an economically depressed section of northeastern Vermont, with some still closed as they continue to repair damage and others urging visitors, who were deterred by the weather, to make the trip
See More Headlines

WBA Stock Analysis - Frequently Asked Questions

Walgreens Boots Alliance's stock was trading at $26.11 at the start of the year. Since then, WBA shares have decreased by 64.7% and is now trading at $9.22.
View the best growth stocks for 2024 here
.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its quarterly earnings results on Thursday, June, 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by $0.05. The company's revenue for the quarter was up 2.8% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Walgreens Boots Alliance: Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and others.

Top institutional investors of Walgreens Boots Alliance include Thompson Siegel & Walmsley LLC (0.70%), Bank of New York Mellon Corp (0.62%), Susquehanna International Group LLP and LSV Asset Management (0.43%). Insiders that own company stock include Walgreens Boots Alliance, Inc, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends
.

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO) and AbbVie (ABBV).

Company Calendar

Last Earnings
6/27/2024
Ex-Dividend for 9/12 Dividend
8/21/2024
Dividend Payable
9/12/2024
Today
9/19/2024
Next Earnings (Confirmed)
10/15/2024
Fiscal Year End
8/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
331,000
Year Founded
2014

Price Target and Rating

Average Stock Price Target
$14.73
High Stock Price Target
$25.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+63.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.87
Research Coverage
15 Analysts

Profitability

Net Income
$-3,080,000,000.00
Pretax Margin
-9.34%

Debt

Sales & Book Value

Annual Sales
$145.53 billion
Cash Flow
$6.58 per share
Book Value
$32.78 per share

Miscellaneous

Free Float
713,065,000
Market Cap
$7.78 billion
Optionable
Optionable
Beta
0.70

Social Links


This page (NASDAQ:WBA) was last updated on 9/19/2024 by MarketBeat.com Staff
From Our Partners